NeuroPace is expected to present its balance sheet figures for the quarter ended December 31, 2021 on March 10, 2022.
Forecasts by 4 analysts expect earnings per share for the past quarter to average -$0.330. This would mean a loss of 94.12 percent compared to the same quarter last year, in which NeuroPace reported -$0.170 per share.
NeuroPace is said to have closed the past quarter with sales totaling USD 11.0 million, according to an average of 3 analysts. This corresponds to an increase in sales of 2.13 percent compared to the same quarter in the previous year, in which $10.8 million had been generated.
The outlook of 4 analysts for the past fiscal year amounts to an average loss per share of -1.881 USD. In the corresponding prior fiscal year, the company had reported a loss per share of -$0.900. On the sales side, 4 analysts expect an average of USD 44.9 million, compared to USD 41.1 million in the previous fiscal year.
Editorial office finanzen.net
Leverage must be between 2 and 20
No data
